Categories
On Twitter

Pfizer raised its forecast for annual sales of its COVID vaccine to $34 billion on demand for Omicron-targeted boosters, helping allay some investor worries over growth for the vaccinations reut.rs/3DQDWlB

Advertisements | Advertising at The News And Times - advertising-newsandtimes.com | WE CONNECT!
Listen to this article
Pfizer raised its forecast for annual sales of its COVID vaccine to $34 billion on demand for Omicron-targeted boosters, helping allay some investor worries over growth for the vaccinations reut.rs/3DQDWlB

Advertisements | Advertising at The News And Times - advertising-newsandtimes.com | WE CONNECT!
WP Radio
WP Radio
OFFLINE LIVE